Securities code: 300006 securities abbreviation: Chongqing Lummy Pharmaceutical Co.Ltd(300006) Announcement No.: 2021-092 Chongqing Lummy Pharmaceutical Co.Ltd(300006)
Announcement on appointment of general counsel of the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) (hereinafter referred to as “the company”) convened the 21st Meeting of the 5th board of directors on December 30, 2021, deliberated and adopted the proposal on the appointment of the company’s general legal adviser. In order to meet the development needs of the company, give full play to the role of the general legal adviser in the legal review and control of operation and management, and promote the company’s legal operation and compliance management, the board of directors of the company agreed to appoint Mr. Cui Dan, deputy general manager and Secretary of the board of directors (attached to the resume), to concurrently serve as the general legal adviser of the company. The term of office is the same as that of the Fifth Board of directors of the company, From December 30, 2021 to June 11, 2023. The independent directors of the company expressed their independent opinions on the appointment of the general legal adviser of the company.
It is hereby announced.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) board of directors December 30, 2021 Annex: Cui Dan’s resume
Mr. Cui Dan, born in July 1980, Chinese nationality, without overseas residency, is a master’s student. Graduated from Sichuan University in 2008, master of economics; From 2008 to 2009, he worked as a securities journalist in the newspaper; From 2010 to April 2018, he worked in the office of the board of directors of the company as a securities affairs representative and has been the manager of the Securities Department of the company since 2012; From June 2017 to July 2021, he served as a supervisor of Chongqing Laimei Health Industry Co., Ltd; From June 2017 to August 2021, he served as the supervisor of Chongqing laimeishu traditional Chinese medicine decoction pieces Co., Ltd; Deputy general manager and Secretary of the board of directors of the company since March 2018.
Up to now, Mr. Cui Dan holds 16844 shares of the company and has no relationship with the actual controller of the company. Except for working in the company and subsidiaries, he has no relationship with other shareholders holding more than 5% of the company’s shares, and there are no conditions prohibited from working in the company law and the articles of association and the punishment of being banned from entering the securities market by the CSRC, There are no circumstances specified in article 3.2.4 of the guidelines for the standardized operation of companies listed on the gem of Shenzhen Stock Exchange, and they are not dishonest Executees.
